146 related articles for article (PubMed ID: 29546614)
21. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells.
Sankpal UT; Goodison S; Jones-Pauley M; Hurtado M; Zhang F; Basha R
Oncotarget; 2017 Feb; 8(9):14593-14603. PubMed ID: 28099934
[TBL] [Abstract][Full Text] [Related]
22. Prenylated caged xanthones: chemistry and biology.
Anantachoke N; Tuchinda P; Kuhakarn C; Pohmakotr M; Reutrakul V
Pharm Biol; 2012 Jan; 50(1):78-91. PubMed ID: 22196584
[TBL] [Abstract][Full Text] [Related]
23. Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency.
Wu Y; Hu M; Yang L; Li X; Bian J; Jiang F; Sun H; You Q; Zhang X
Bioorg Med Chem Lett; 2015 Jun; 25(12):2584-8. PubMed ID: 25958244
[TBL] [Abstract][Full Text] [Related]
24. Molecular targets of gambogic acid in cancer: recent trends and advancements.
Kashyap D; Mondal R; Tuli HS; Kumar G; Sharma AK
Tumour Biol; 2016 Oct; 37(10):12915-12925. PubMed ID: 27448303
[TBL] [Abstract][Full Text] [Related]
25. Novel Xanthone Derivatives Impair Growth and Invasiveness of Colon Cancer Cells In Vitro.
Rech J; Sypniewski D; Żelaszczyk D; Szkaradek N; Rogóż W; Waszkielewicz A; Marona H; Bednarek I
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680113
[TBL] [Abstract][Full Text] [Related]
26. PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer.
El Fitori J; Su Y; Büchler P; Ludwig R; Giese NA; Büchler MW; Quentmeier H; Hines OJ; Herr I; Friess H
Cancer; 2007 Oct; 110(7):1457-68. PubMed ID: 17676584
[TBL] [Abstract][Full Text] [Related]
27. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
28. Gambogic acid down-regulates MDM2 oncogene and induces p21(Waf1/CIP1) expression independent of p53.
Rong JJ; Hu R; Qi Q; Gu HY; Zhao Q; Wang J; Mu R; You QD; Guo QL
Cancer Lett; 2009 Oct; 284(1):102-12. PubMed ID: 19428175
[TBL] [Abstract][Full Text] [Related]
29. Studies on chemical structure modification and structure-activity relationship of derivatives of gambogic acid at C(39).
Sun HP; Liu ZL; Xue X; Gao Y; Zhang L; Wang JX; Guo QL; You QD
Chem Biodivers; 2012 Aug; 9(8):1579-90. PubMed ID: 22899618
[TBL] [Abstract][Full Text] [Related]
30. Gambogic acid sensitizes ovarian cancer cells to doxorubicin through ROS-mediated apoptosis.
Wang J; Yuan Z
Cell Biochem Biophys; 2013 Sep; 67(1):199-206. PubMed ID: 23436279
[TBL] [Abstract][Full Text] [Related]
31. Variability in statin-induced changes in gene expression profiles of pancreatic cancer.
Gbelcová H; Rimpelová S; Ruml T; Fenclová M; Kosek V; Hajšlová J; Strnad H; Kolář M; Vítek L
Sci Rep; 2017 Mar; 7():44219. PubMed ID: 28276528
[TBL] [Abstract][Full Text] [Related]
32. Studies on chemical structure modification and biology of a natural product, gambogic acid (I): Synthesis and biological evaluation of oxidized analogues of gambogic acid.
Wang J; Zhao L; Hu Y; Guo Q; Zhang L; Wang X; Li N; You Q
Eur J Med Chem; 2009 Jun; 44(6):2611-20. PubMed ID: 18996626
[TBL] [Abstract][Full Text] [Related]
33. Crucial microRNAs and genes in metformin's anti-pancreatic cancer effect explored by microRNA-mRNA integrated analysis.
Li Y; Li L; Zhang G; Wang Y; Chen H; Kong R; Pan S; Sun B
Invest New Drugs; 2018 Feb; 36(1):20-27. PubMed ID: 28875433
[TBL] [Abstract][Full Text] [Related]
34. Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade.
Johnson JL; de Mejia EG
Mol Nutr Food Res; 2013 Dec; 57(12):2112-27. PubMed ID: 23943362
[TBL] [Abstract][Full Text] [Related]
35. Global profiling of cellular targets of gambogic acid by quantitative chemical proteomics.
Zhou Y; Li W; Zhang X; Zhang H; Xiao Y
Chem Commun (Camb); 2016 Nov; 52(97):14035-14038. PubMed ID: 27853763
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationship of Garcinia xanthones analogues: Potent Hsp90 inhibitors with cytotoxicity and antiangiogenesis activity.
Xu X; Wu Y; Hu M; Li X; Gu C; You Q; Zhang X
Bioorg Med Chem; 2016 Oct; 24(19):4626-4635. PubMed ID: 27527413
[TBL] [Abstract][Full Text] [Related]
37. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression.
Wang S; Wang L; Chen M; Wang Y
Chem Biol Interact; 2015 Jun; 235():76-84. PubMed ID: 25824409
[TBL] [Abstract][Full Text] [Related]
38. Gambogic acid induces EGFR degradation and Akt/mTORC1 inhibition through AMPK dependent-LRIG1 upregulation in cultured U87 glioma cells.
He XY; Liu XJ; Chen X; Bian LG; Zhao WG; Shen JK; Sun QF
Biochem Biophys Res Commun; 2013 Jun; 435(3):397-402. PubMed ID: 23665322
[TBL] [Abstract][Full Text] [Related]
39. Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells.
Wang T; Wei J; Qian X; Ding Y; Yu L; Liu B
Cancer Lett; 2008 Apr; 262(2):214-22. PubMed ID: 18248784
[TBL] [Abstract][Full Text] [Related]
40. Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system.
Felth J; Lesiak-Mieczkowska K; D'Arcy P; Haglund C; Gullbo J; Larsson R; Linder S; Bohlin L; Fryknäs M; Rickardson L
Invest New Drugs; 2013 Jun; 31(3):587-98. PubMed ID: 23179339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
